falseIngevity Corp000165347700016534772021-04-222021-04-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________________________ 
FORM 8-K
_______________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

April 22, 2021
Date of Report (date of earliest event reported)
__________________________________________________________________________
NGVT-20210422_G1.JPG
INGEVITY CORPORATION
(Exact name of registrant as specified in its charter)
__________________________________________________________________________ 
Delaware 001-37586 47-4027764
(State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.)
4920 O'Hear Avenue Suite 400 North Charleston South Carolina 29405
(Address of principal executive offices) (Zip code)


Registrant’s telephone number, including area code: 843-740-2300

Not Applicable
(Former name or former address, if changed since last report)
_____________________________________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock ($0.01 par value) NGVT New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act o
_____________________________________________________________________________________________________


ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

On April 22, 2021, Ingevity Corporation (the "Company") held its 2021 Annual Meeting, at which the Company’s stockholders voted on the three proposals identified below. Each of the proposals are described in more detail in the Company's definitive Proxy Statement, which was filed with the Securities and Exchange Commission on March 8, 2021.
    
There were 42,934,785 shares of the Company’s common stock issued and outstanding on the record date and entitled to vote at the Annual Meeting, and 38,054,430 shares (88.63%) were represented in person or by proxy at the Annual Meeting, which number constituted a quorum.
    
Proposals No. 1, 2, and 3 were approved by the requisite vote of the Company’s stockholders. The final voting results for each proposal are described below.


1. A proposal to elect the eight (8) director candidates listed below, each for a one-year term or until his or her successor is duly elected and qualified:
FOR AGAINST ABSTAIN BROKER NON-VOTE
Jean S. Blackwell 36,082,795 316,265 27,691 1,627,679
Luis Fernandez-Moreno 36,012,692 379,806 34,253 1,627,679
J. Michael Fitzpatrick 35,959,002 433,394 34,335 1,627,679
John C. Fortson 36,000,241 391,742 34,768 1,627,679
Diane H. Gulyas 36,006,491 391,854 28,406 1,627,679
Frederick J. Lynch 35,609,413 783,126 34,212 1,627,679
Karen G. Narwold 36,007,309 391,739 27,703 1,627,679
Daniel F. Sansone 36,036,651 355,791 34,309 1,627,679


2. Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2021.
FOR AGAINST ABSTAIN
37,977,360 51,558 25,512

3. Approve on an advisory basis (non-binding) the compensation paid to our named executive officers (Say-on-Pay).
FOR AGAINST ABSTAIN BROKER NON-VOTE
34,405,004 1,954,304 67,443 1,627,679


ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.
Exhibit No. Description of Exhibit
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INGEVITY CORPORATION
(Registrant)
By: /S/ STACY L. COZAD
Stacy L. Cozad
Executive Vice President, General Counsel and Secretary
Date: April 22, 2021


Ingevity (NYSE:NGVT)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Ingevity Charts.
Ingevity (NYSE:NGVT)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Ingevity Charts.